This page lists the SEC filings reported by Novo Holdings A/S.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2023-06-06 | Novo Holdings A/S | LAVA Therapeutics NV | 2,400,000 | 9.1% | EDGAR |
| SC 13G/A | 2023-05-26 | Novo Holdings A/S | VectivBio Holding AG | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-05-15 | Novo Holdings A/S | Reneo Pharmaceuticals, Inc. | 3,430,377 | 10.2% | EDGAR |
| SC 13D/A | 2023-02-24 | Novo Holdings A/S | LAVA Therapeutics NV | 3,070,558 | 11.7% | EDGAR |
| SC 13D/A | 2023-02-21 | Novo Holdings A/S | SPRUCE BIOSCIENCES, INC. | 8,378,336 | 19.9% | EDGAR |
| SC 13G | 2023-02-17 | Novo Holdings A/S | LanzaTech Global, Inc. | 15,814,845 | 8.1% | EDGAR |
| SC 13G/A | 2023-02-02 | Novo Holdings A/S | Evotec SE | 17,444,807 | 9.8% | EDGAR |
| SC 13G/A | 2023-02-02 | Novo Holdings A/S | VectivBio Holding AG | 3,339,484 | 5.3% | EDGAR |
| SC 13D/A | 2023-01-04 | Novo Holdings A/S | Bolt Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-01-03 | Novo Holdings A/S | Disc Medicine, Inc. | 2,340,772 | 13.8% | EDGAR |
| SC 13D/A | 2022-12-28 | Novo Holdings A/S | Bolt Biotherapeutics, Inc. | 2,534,465 | 6.7% | EDGAR |
| SC 13G/A | 2022-12-12 | Novo Holdings A/S | Arcellx, Inc. | 1,750,000 | 4.0% | EDGAR |
| SC 13G/A | 2022-11-28 | Novo Holdings A/S | Arcellx, Inc. | 2,507,076 | 5.7% | EDGAR |
| SC 13G | 2022-11-17 | Novo Holdings A/S | Rallybio Corp | 2,296,007 | 6.2% | EDGAR |
| SC 13G/A | 2022-11-03 | Novo Holdings A/S | MINERVA SURGICAL INC | 1,322,473 | 4.5% | EDGAR |
| SC 13D/A | 2022-10-24 | Novo Holdings A/S | Milestone Pharmaceuticals Inc. | 1,378,538 | 4.6% | EDGAR |
| SC 13D/A | 2022-10-03 | Novo Holdings A/S | LAVA Therapeutics NV | 3,327,312 | 12.9% | EDGAR |
| SC 13D/A | 2022-09-30 | Novo Holdings A/S | Cyteir Therapeutics, Inc. | 3,940,413 | 11.1% | EDGAR |
| SC 13D/A | 2022-09-30 | Novo Holdings A/S | Reneo Pharmaceuticals, Inc. | 3,430,377 | 14.0% | EDGAR |
| SC 13D/A | 2022-09-30 | Novo Holdings A/S | LAVA Therapeutics NV | 3,327,312 | 8.6% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.